Photodynamic therapy (PDT) utilizing Photofrin is proving to be effective for the treatment of early stage lung cancers. The effect of PDT utilizing YAG-OPO laser as new light source was evaluated in 26 patients (29 lesions) with early stage lung cancers. YAG-OPO laser is solid state tunable laser which is easy to change wavelength between 620 and 670 nm exciting various kinds of photosensitizers. Moreover, YAG-OPO laser is more reliable, smaller and has less consumables than argon-dye laser or excimer-dye laser. As the result of PDT with YAG-OPO laser, complete remission (CR) was obtained in 82.6% of the 29 lesions, partial remission (PR) in 13.8% and no change (NC) was obtained in 3.4%. We conclude that PDT utilizing YAG-OPO laser is efficacious in the treatment of early stage lung cancers and can achieve complete remission.
INTRODUCTION
Increasing numbers of early stage lung cancer cases are being detected as a result of improved survey and diagnostic techniques. Despite the possibility of curative resection in many such cases, many of the patients are frequently at high surgical risk because of coexisting chronic obstructive pulmonary disease or cardiovascular disease. Considering the quality of life of the patients, it is esCorresponding author.
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sential to preserve lung tissue by treating the initial early stage lung cancer as conservatively as possible. The introduction of photodynamic therapy (PDT) has provided a new therapeutic alternative to surgery. PDT is a new cancer treatment modality that selectively destroys cancer cells by an interaction between absorbed light and a retained photosensitizer [1, 2] . Since 
PATIENTS AND METHODS

Patient Eligibility
Eligibility criteria were as follows: (1) [6] .
The excimer-dye laser consists of a gas and dye laser, which means that the system is large and the maintenance cost is high. Therefore, a small solid state laser would be useful for PDT. Since the YAG-OPO laser is all solid state laser except for the flash lamps, it is more reliable, smaller and has less consumables than argon-dye laser or excimer-dye laser [4] . Moreover, the tunability of its wavelength enables it to be used with various kinds of photosensitizers; hematoporphyrin derivative (630 nm), 5-ALA (630 nm), pheophorbide-a (650nm), mono-L-aspartyl chlorin e6 (664nm), aluminum phthalocyanine (670 nm), etc [7] .
In a multi-center research study in Japan on early stage lung cancer treated by PDT with Photfrin and excimer-dye laser involving 66 carcinomas, CR was achieved in 51 carcinomas (77.3 %) after the initial PDT [8, 9] . Our results with the YAG-OPO laser were by no means inferior to those data and also there was no serious adverse effect by the laser itself except slight skin photosensitivity which was caused by Photofrin. These data encourage the future clinical use of the YAG-OPO laser.
We previously reported that complete remission was difficult to obtain in lesions which were anatomically difficult to photoirradiate. However, the side irradiating tip made it possible to photoradiate from an angle of 90 to the surface of the lesion in this study. 
